Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Card Drug Prices Are 72% Higher Than In Canada, Rep. Waxman Study Says

This article was originally published in The Pink Sheet Daily

Executive Summary

The analysis indicates that pressure to legalize drug importation will not be mitigated by the launch of the Medicare drug discount card. The total price for ten drugs commonly used by seniors would be $596 in Canada, compared to an average of $1,026 through three Medicare discount cards.

You may also be interested in...



CMS Report Highlights Drug Card Savings For Chronic Conditions

In an analysis of the best drug card prices for 23 drugs used to treat nine chronic conditions, CMS found that savings range from 10% to 75%, when compared to the national average retail monthly price. Treatment savings can also be attained with drug cards offering less-than-optimal discounts, the report says.

CMS Report Highlights Drug Card Savings For Chronic Conditions

In an analysis of the best drug card prices for 23 drugs used to treat nine chronic conditions, CMS found that savings range from 10% to 75%, when compared to the national average retail monthly price. Treatment savings can also be attained with drug cards offering less-than-optimal discounts, the report says.

Medicare Rx Price Comparison Website Goes Live With Data From Half Of Cards

About half of the plans listed by name on the site have yet to gain final marketing approval pending clearance of promotional materials or demonstration of compatibility with CMS' systems.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS059289

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel